{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T09:09:06Z","timestamp":1779008946548,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jviromet.2026.115375","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:51:11Z","timestamp":1771433471000},"page":"115375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Detection of cell impurities and NF-\u03baB activation using SEAP reporter cell lines in vaccines"],"prefix":"10.1016","volume":"343","author":[{"given":"Sarah K.","family":"Mercier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Gilmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-4786","authenticated-orcid":false,"given":"Jackson","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie","family":"Latta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearl","family":"Bamford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidyani","family":"Manatunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Carscadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2026.115375_bib1","unstructured":"Therapeutic Goods Administration. Seasonal flu vaccine: Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination: Department of Health and Aged Care; 2010 [cited 20 November 2024]. Available from: \u3008https:\/\/www.tga.gov.au\/seasonal-flu-vaccine-investigation-febrile-reactions-young-children-following-2010-seasonal-trivalent-influenza-vaccination\u3009."},{"issue":"30","key":"10.1016\/j.jviromet.2026.115375_bib2","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/j.vaccine.2014.03.032","article-title":"Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere Trivalent Influenza Vaccine is associated with adverse events","volume":"32","author":"Rockman","year":"2014","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.jviromet.2026.115375_bib3","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.vaccine.2014.03.035","article-title":"Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine","volume":"32","author":"Rockman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2026.115375_bib4","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1016\/j.vaccine.2015.10.080","article-title":"The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper","volume":"33","author":"Halsey","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jviromet.2026.115375_bib5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/biology12060776","article-title":"New Insights into NF-\u03baB Signaling in Innate Immunity: Focus on Immunometabolic Crosstalks","volume":"12","author":"Iacobazzi","year":"2023","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115375_bib6","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jviromet.2026.115375_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.jviromet.2026.115375_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310804","article-title":"Lawsonia intracellularis regulates nuclear factor-\u03baB signalling pathway during infection","volume":"19","author":"Yang","year":"2024","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115375_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"15, 2020","key":"10.1016\/j.jviromet.2026.115375_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu Rev. Pathol Mech. Dis."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115375_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125078","article-title":"Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins","volume":"10","author":"Haile","year":"2015","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.jviromet.2026.115375_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40360-016-0113-6","article-title":"Identification and application of anti-inflammatory compounds screening system based on RAW264.7 cells stably expressing NF-\u03baB-dependent SEAP reporter gene","volume":"18","author":"Li","year":"2017","journal-title":"BMC Pharm. Toxicol."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115375_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178220","article-title":"A human monocytic NF-\u03baB fluorescent reporter cell line for detection of microbial contaminants in biological samples","volume":"12","author":"Battin","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jviromet.2026.115375_bib14","unstructured":"International Council for Harmonisation. Validation of analytical procedures: Text and methology Q2(R1) - ICH Harmonised Tripartite Guideline. 2005."},{"issue":"1","key":"10.1016\/j.jviromet.2026.115375_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2024.184394","article-title":"TNF receptors: Structure-function relationships and therapeutic targeting strategies","volume":"1867","author":"Lo","year":"2025","journal-title":"Biochim. Et. Biophys. Acta (BBA) Biomembr."},{"key":"10.1016\/j.jviromet.2026.115375_bib16","unstructured":"National Institute for Biological Standards and Control. 3rd International Standard for Tumour Necrosis Factor-alpha (Human, rDNA derived) - NIBSC code: 17\/232. Hertforshire, England 2013."},{"issue":"7","key":"10.1016\/j.jviromet.2026.115375_bib17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115375_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nri2301","article-title":"TLR4 signalling","volume":"8","author":"Bell","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"29","key":"10.1016\/j.jviromet.2026.115375_bib19","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1016\/j.vaccine.2018.05.073","article-title":"Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study","volume":"37","author":"Studholme","year":"2019","journal-title":"Vaccine"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609342600039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609342600039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:29:13Z","timestamp":1779006553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016609342600039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":19,"alternative-id":["S016609342600039X"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115375","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of cell impurities and NF-\u03baB activation using SEAP reporter cell lines in vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115375"}}